Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 5,000 shares at $50.96 ($255K) on 2009-11-02, disclosed to the SEC on 2009-11-04.
Scheduled sale ($255k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.93 | 100 | $5K | 2.0% |
| 2 | $50.95 | 4,200 | $214K | 84.0% |
| 3 | $50.96 | 400 | $20K | 8.0% |
| 4 | $50.97 | 300 | $15K | 6.0% |
| Total | $50.95 avg | 5,000 | $255K | 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |